Huisheng Biotech: Announcement on changing registered capital, business scope and amending the Articles of Association
Securities code: 300871 Securities abbreviation: Huisheng Biotechnology Announcement number: 2026-008
Wuhan Huisheng Biotechnology Co., Ltd.
Announcement on changing the registered capital, business scope and amending the "Articles of Association"
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Wuhan Huisheng Biotechnology Co., Ltd. (hereinafter referred to as the "Company") held the fourth meeting of the fourth board of directors on February 4, 2026, and reviewed and approved the "Proposal on Changing the Registered Capital, Business Scope and Amending the Articles of Association". This proposal still needs to be submitted to the company's first extraordinary shareholders' meeting in 2026 for review. The relevant matters are now announced as follows:
1. Changes in registered capital
As the company canceled 548,200 shares in the special account for repurchase, the company's total share capital was reduced by 548,200 shares and its registered capital was reduced by 548,200 yuan.
In view of the above changes in the total number of shares, the company changed the total share capital from 202,332,557 shares to 201,784,357 shares, the registered capital from 202,332,557 yuan to 201,784,357 yuan, and revised Articles 6 and 20 of the Articles of Association.
2. Changes in business scope
According to business development needs, the company plans to add "daily groceries manufacturing, pet food and supplies wholesale, sanitary products and disposable medical supplies production, sanitary supplies and disposable medical supplies sales" within the original business scope. Therefore, the company plans to change its business scope and amend the corresponding provisions of the Articles of Association.
3. Proposed amendments to the Company’s Articles of Association
Based on the changes in registered capital and business scope, the company plans to revise the corresponding provisions of the Articles of Association. The details are as follows:
Before revision After revision
Article 6 The registered capital of the company is RMB 202,332,557. Article 6 The registered capital of the company is RMB 201,784,357. Yuan.
Article 15 The company’s business scope:
Licensed projects: veterinary drug production; veterinary drug business; feed additives
Article 15 The company’s business scope:
Production; feed production; fertilizer production; disinfectant production (non-permitted items: veterinary drug production; veterinary drug business; feed additives
containing hazardous chemicals); sanitary products and disposable medical production; feed production; fertilizer production; disinfectant production (not
Supplies production.
Contains hazardous chemicals).
General items: sales of feed additives; sales of livestock and fishery feeds General items: sales of feed additives; sales of livestock and fishery feeds
sales; biological feed research and development; chemical product production (excluding licensed sales; biological feed research and development; chemical product production (excluding licensed
chemical products); sales of chemical products (excluding licensed chemical products); sales of chemical products (excluding licensed chemical products)
industrial products); manufacturing of special chemical products (excluding hazardous chemical industrial products); manufacturing of special chemical products (excluding hazardous chemical products)
products); sales of special chemical products (excluding hazardous chemicals); products); sales of special chemical products (excluding hazardous chemicals);
Bio-organic fertilizer research and development; fertilizer sales; compound microbial fertilizer bio-organic fertilizer research and development; fertilizer sales; compound microbial fertilizer
Research and development of materials; sales of disinfectants (excluding hazardous chemicals); research and development of technical materials; sales of disinfectants (excluding hazardous chemicals); technology
technical services, technical development, technical consulting, technical exchanges, technical services, technical development, technical consulting, technical exchanges, technical
Technology transfer and technology promotion; non-residential real estate leasing; daily technology transfer and technology promotion; non-residential real estate leasing.
Manufacturing of miscellaneous goods; wholesale of pet food and supplies; sanitary products and the company's business scope shall be subject to matters approved by the registration authority.
Disposable medical supplies sales.
The company's business scope shall be subject to matters approved by the registration authority.
Article 20 The total number of shares of the company is 202,332,557. Article 20 The total number of shares of the company is 201,784,357 shares, all of which are ordinary shares and there are no other types of shares. The shares are all ordinary shares and there are no other types of shares.
Except for the revision of the above terms, the content of other terms remains unchanged.
4. Other instructions
(1) The fourth meeting of the company’s fourth session of the board of directors reviewed and approved the “Proposal on Changing the Registered Capital, Business Scope and Amending the Articles of Association.” This proposal still needs to be submitted to the company’s first extraordinary shareholders’ meeting in 2026 for review, and it must be approved by more than two-thirds of the voting rights held by those present at the shareholders’ meeting. The shareholders’ meeting authorizes the company’s management to handle the industrial and commercial registration and filing procedures for this change in registered capital.
(2) Modifications to the relevant articles of this Articles of Association are ultimately subject to the review of the shareholders’ meeting and the approval results of the Wuhan Municipal Administrative Approval Service Agency.
5. Documents for reference
Resolution of the fourth meeting of the fourth board of directors.
Announcement is hereby made.
Board of Directors of Wuhan Huisheng Biotechnology Co., Ltd.
February 6, 2026